Cargando…

Prognostic impact of Bacillus Calmette-Guérin interruption at the time of induction and consolidation

CONTEXT: Intravesical Bacillus Calmette-Guérin (BCG) is a cause of bladder and systemic toxicity that is difficult to prevent and is responsible for treatment drop out in bladder cancer patients. More recently, BCG shortage has become the main cause of incomplete treatment. AIMS: The aim of this stu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alhogbani, M. Mofarej, Picard, J. Aude, Fassi-Fehri, M. Hakim, Badet, J. Lionel, Colombel, C. Marc
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5656953/ https://www.ncbi.nlm.nih.gov/pubmed/29118530 http://dx.doi.org/10.4103/UA.UA_115_17

Ejemplares similares

Bacillus Calmette–Guérin Immunotherapy for Cancer
por: Cardillo, Fabíola, et al.
Publicado: (2021)

VARIABILITY OF BCG STRAINS (BACILLUS CALMETTE-GUÉRIN)
por: Suter, W. Emanuel, et al.
Publicado: (1951)

100 years of the Bacillus Calmette-Guérin vaccine
por: Bettencourt, Paulo J.G., et al.
Publicado: (2021)

Bacillus Calmette-Guerin (BCG): the adroit vaccine
por: Adesanya, Oluwafolajimi A., et al.
Publicado: (2021)

Disseminated Bacillus Calmette-Guérin Infection and Immunodeficiency
por: Bernatowska, Ewa Anna, et al.
Publicado: (2007)

Bacillus Calmette-Guerin (BCG) vaccine in Iran
por: Fallah, Fatemeh, et al.
Publicado: (2018)

Bacillus Calmette-Guerin Vaccine and Nonspecific Immunity
por: Parmar, Kanak, et al.
Publicado: (2021)

Clinical Course of Bacillus Calmette-Guerin Lymphadenitis
por: Ko, Dayoung, et al.
Publicado: (2022)

Predictive biomarkers of response to bacillus Calmette‐Guérin immunotherapy and bacillus Calmette‐Guérin failure for non‐muscle invasive bladder cancer
por: Wang, Ziting, et al.
Publicado: (2022)

THE HOST RESPONSE TO CALMETTE-GUÉRIN BACILLUS INFECTION IN MICE
por: Blanden, R. V., et al.
Publicado: (1969)

Differential induction of innate memory in porcine monocytes by β-glucan or bacillus Calmette-Guerin
por: Byrne, Kristen A, et al.
Publicado: (2020)

Bacillus Calmette-Guérin in the management of superficial bladder cancer
por: Kapoor, Rakesh, et al.
Publicado: (2008)

Sternal Osteomyelitis after Bacillus Calmette-Guérin Vaccination
por: Selvestravičius, Rolandas, et al.
Publicado: (2016)

Unraveling the Mechanism of the Antitumor Activity of Bacillus Calmette-Guérin
por: Li, Roger, et al.
Publicado: (2020)

COVID-19 and Bacillus Calmette-Guérin: What is the Link?
por: Hegarty, Paul K., et al.
Publicado: (2020)

Bacillus Calmette–Guérin in Immuno-Regulation of Alzheimer’s Disease
por: Klein, Benjamin Y., et al.
Publicado: (2022)

Recognition and destruction of Bacillus Calmette-Guerin-infected human monocytes
Publicado: (1993)

Oral bacillus Calmette-Guérin vaccine against tuberculosis: why not?
por: Monteiro-Maia, Renata, et al.
Publicado: (2014)

Managing the adverse events of intravesical bacillus Calmette–Guérin therapy
por: Decaestecker, Karel, et al.
Publicado: (2015)

Disseminated Bacillus Calmette-Guérin (BCG) infections in infants with immunodeficiency
por: Al-Hammadi, Suleiman, et al.
Publicado: (2017)

Newly sequenced genomes of four Bacillus Calmette Guerin vaccines
por: Sisco, Maria Carolina, et al.
Publicado: (2020)

Bacillus Calmette-Guérin (BCG) Therapy for Bladder Cancer: An Update
por: Guallar-Garrido, Sandra, et al.
Publicado: (2020)

Tuberculous Spondylitis Caused by Intravesical Bacillus Calmette-Guerin Therapy
por: Minakata, Tomokazu, et al.
Publicado: (2020)

Erythema at the bacillus Calmette-Guerin scar after influenza vaccination
por: Chavarri-Guerra, Yanin, et al.
Publicado: (2019)

Severity of COVID-19 in bacillus Calmette-Guérin vaccinated population
por: Khanum, Iffat, et al.
Publicado: (2021)

An ambivalent prostate nodule after Bacillus Calmette-Guérin therapy
por: Sauvat, L., et al.
Publicado: (2021)

Reactive Arthritis After Intravesical Bacillus Calmette-Guérin Therapy
por: Taniguchi, Yoshinori, et al.
Publicado: (2022)

Bacillus Calmette-Guérin (BCG) Brazilian Backstage in Bladder Cancer
Publicado: (2021)

Bacillus Calmette-Guérin vaccine-related complications in children in Oman
por: Al Waili, Badria, et al.
Publicado: (2021)

Novel personalized cancer vaccine platform based on Bacillus Calmette-Guèrin
por: Ylösmäki, Erkko, et al.
Publicado: (2021)

Discriminators of mouse bladder response to intravesical Bacillus Calmette-Guerin (BCG)
por: Saban, Marcia R, et al.
Publicado: (2007)

FNAC of Bacillus- Calmette- Guerin lymphadenitis masquerading as Langerhans cell histiocytosis.
por: Gupta, Nalini, et al.
Publicado: (2004)

Generalized Granuloma Annulare in Infancy Following Bacillus Calmette-Guerin Vaccination
por: Lee, Sang Woo, et al.
Publicado: (2011)

Mycobacterium bovis spondylodiscitis after intravesical Bacillus Calmette-Guérin therapy
por: Obaid, Sami, et al.
Publicado: (2011)

Infantile osteoarticular tuberculosis misdiagnosed as Bacillus Calmette-Guerin related osteomyelitis
por: Limpaphayom, Noppachart, et al.
Publicado: (2015)

Acute Hepatitis and Pneumonitis Caused by Disseminated Bacillus Calmette-Guérin Infection
por: Dibs, Khaled, et al.
Publicado: (2016)

Positive impact of rescheduling Bacillus Calmette-Guérin vaccination on vaccinations at birth
por: Oberoi, Simmi, et al.
Publicado: (2017)

Granulomatous hepatitis as a rare complication of Bacillus Calmette-Guérin vaccination
por: Shoaran, Maryam, et al.
Publicado: (2013)

Intravesical bacillus Calmette-Guérin for bladder cancer: are all the strains equal?
por: D’Andrea, David, et al.
Publicado: (2019)

Use of the Human Vaccine, Mycobacterium bovis Bacillus Calmette Guérin in Deer
por: Palmer, Mitchell V., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_6h7n4m2rgevtmgat6gkokd20vv